BMI1 as a novel target for drug discovery in cancer

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2729-2741

  Cao, Liangxian ^a   Bombard, Jenelle ^a   Cintron, Katherine ^a   Sheedy, Josephine ^a   Weetall, Marla L ^a   Davis, Thomas W ^a  

^a PTC THERAPEUTICS   (United States)

Author keywords

BMI1; cancer stem cells; cancer therapeutic target; plolycomb repressive protein; post transcriptional control

Indexed keywords

BMI1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL AGING; CHROMATIN STRUCTURE; GENE AMPLIFICATION; HUMAN; IN VITRO STUDY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; TUMOR CELL;

ANIMALS; HUMANS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS;

EID: 80053217527     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23234     Document Type: Article

References (85)

1. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G,. 2009. BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29: 8884-8896.
2. Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M,. 2009. Polycomb mediated epigenetic silencing and replication timing at the Ink4a/ARF locus during senescence. PLoS ONE 4: e5622.
3. Alkema MJ, Wiegant J, Raap AK, Berns A, van Lohuizen M,. 1993. Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Genet 2: 1597-1603. (Pubitemid 23358676)
4. Bea S, Tort F, Pinyol M, Puig X, Hernandez L, Hernandez S, Fernandez PL, van Lohuizen LM, Colomer D, Campo E,. 2001. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 61: 2409-2412. (Pubitemid 32685815)
5. Bhattacharyya J, Mihara K, Yasunaga S, Tanaka H, Hoshi M, Takihara Y, Kimura A,. 2009. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Ann Hematol 88: 333-340.
6. Bommi PV, Dimri M, Sahasrabuddhe AA, Khandekar J, Dimri GP,. 2010. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Cell Cycle 9: 2663-2673.
7. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K,. 2006. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20: 1123-1136.
8. Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J, van Tellengen TO, van Lohuizen M,. 2007. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12: 328-341. (Pubitemid 47539307)
9. Cao R, Tsukada Y, Zhang Y,. 2005. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20: 845-854. (Pubitemid 41814874)
10. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, Bernier G,. 2009. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 29: 529-542.
11. Chiba T, Seki A, Aoki R, Ichikawa H, Negishi M, Miyagi S, Oguro H, Saraya A, Kamiya A, Nakauchi H, Yokosuka O, Iwama A,. 2010. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Hepatology 52: 1111-1123.
12. Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, Kimura A,. 2007. Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21: 1116-1122. (Pubitemid 46672096)
13. Courel M, Friesenhahn L, Lees JA,. 2008. E2f6 and Bmi1 cooperate in axial skeletal development. Dev Dyn 237: 1232-1242. (Pubitemid 351668809)
14. Dean M,. 2009. ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14: 3-9.
15. Dong Q, Oh JE, Chen W, Kim R, Kim RH, Shin KH, McBride WH, Park NH, Kang MK,. 2011. Radioprotective effects of bmi-1 involve epigenetic silencing of oxidase genes and enhanced DNA repair in normal human keratinocytes. J Invest Dermatol 131: 1216-1225.
16. Facchino S, Abdouh M, Chatoo W, Bernier G,. 2010. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 30: 10096-10111.
17. Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC, Tang D,. 2009. PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer 8: 98.
18. Gao MQ, Choi YP, Kang S, Youn JH, Cho NH,. 2010. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29: 2672-2680.
19. Ginjala V, Nacerddine K, Kulkarni A, Oza J, Hill SJ, Yao M, Citterio E, van Lohuizen M, Ganesan S,. 2011. BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair. Mol Cell Biol 31: 1972-1982.
20. Glinsky GV,. 2007. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers. Stem Cell Rev 3: 79-93. (Pubitemid 47472815)
21. Guney I, Wu S, Sedivy JM,. 2006. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(Ink4a). Proc Natl Acad Sci USA 103: 3645-3650. (Pubitemid 43376609)
22. Guo WJ, Datta S, Band V, Dimri GP,. 2007. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 18: 536-546. (Pubitemid 46213222)
23. Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS,. 2011. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 10: 10.
24. Haupt Y, Bath ML, Harris AW, Adams JM,. 1993. bmi-1 Transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 8: 3161-3164. (Pubitemid 23312924)
25. Hayry V, Tanner M, Blom T, Tynninen O, Roselli A, Ollikainen M, Sariola H, Wartiovaara K, Nupponen NN,. 2008. Copy number alterations of the polycomb gene BMI1 in gliomas. Acta Neuropathol 116: 97-102.
26. Hernandez-Munoz I, Taghavi P, Kuijl C, Neefjes J, van Lohuizen M,. 2005. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol Cell Biol 25: 11047-11058. (Pubitemid 41747146)
27. Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP, Green JE,. 2009. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 28: 3022-3032.
28. Honig A, Weidler C, Hausler S, Krockenberger M, Buchholz S, Koster F, Segerer SE, Dietl J, Engel JB,. 2010. Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Res 30: 1559-1564.
29. Hosen N, Yamane T, Muijtjens M, Pham K, Clarke MF, Weissman IL,. 2007. Bmi-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells. Stem Cells 25: 1635-1644. (Pubitemid 47121840)
30. Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE,. 2009. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 69: 8241-8248.
31. Ismail IH, Andrin C, McDonald D, Hendzel MJ,. 2010. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol 191: 45-60.
32. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ, van Lohuizen M, Band V, Campisi J, Dimri GP,. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 23: 389-401. (Pubitemid 36008529)
33. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M,. 1999a. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the Ink4a locus. Nature 397: 164-168. (Pubitemid 29050921)
34. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M,. 1999b. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via Ink4a/ARF. Genes Dev 13: 2678-2690. (Pubitemid 29508555)
35. Jiang L, Li J, Song L,. 2009. Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 41: 527-534.
36. Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS,. 2010. Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci 67: 1165-1176.
37. Kajiume T, Ohno N, Sera Y, Kawahara Y, Yuge L, Kobayashi M,. 2009. Reciprocal expression of Bmi1 and Mel-18 is associated with functioning of primitive hematopoietic cells. Exp Hematol 37: 857-866.
38. Kerppola TK,. 2009. Polycomb group complexes-Many combinations, many functions. Trends Cell Biol 19: 692-704.
39. Kim J, Wong PK,. 2009a. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J Biol Chem 284: 14396-14404.
40. Kim J, Wong PK,. 2009b. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J Biol Chem 284: 14396-14404.
41. Kim RH, Kang MK, Shin KH, Oo ZM, Han T, Baluda MA, Park NH,. 2007. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes. Exp Cell Res 313: 462-472. (Pubitemid 46186301)
42. Kim J, Hwangbo J, Wong PK,. 2011. p38 MAPK-mediated Bmi-1 down-regulation and defective proliferation in ATM-deficient neural stem cells can be restored by Akt activation. PLoS ONE 6: e16615.
43. Kimura M, Takenobu H, Akita N, Nakazawa A, Ochiai H, Shimozato O, Fujimura YI, Koseki H, Yoshino I, Kimura H, Nakagawara A, Kamijo T,. 2011. Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Cancer Sci 102: 983-990.
44. Kuerbitz SJ, Malandro J, Compitello N, Baylin SB, Graff JR,. 1999. Deletion of 16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors. Cell Growth Differ 10 (1): 27-33. (Pubitemid 29086916)
45. Lessard J, Sauvageau G,. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260. (Pubitemid 40852690)
46. Li Z, Cao R, Wang M, Myers MP, Zhang Y, Xu RM,. 2006. Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J Biol Chem 281: 20643-20649. (Pubitemid 44065835)
47. Li SK, Smith DK, Leung WY, Cheung AM, Lam EW, Dimri GP, Yao KM,. 2008. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem 283: 16545-16553.
48. Li C, Lee CJ, Simeone DM,. 2009. Identification of human pancreatic cancer stem cells. Methods Mol Biol 568: 161-173.
49. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH,. 2010. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 136: 997-1006.
50. Liu L, Andrews LG, Tollefsbol TO,. 2006a. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 25: 4370-4375. (Pubitemid 44100507)
51. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS,. 2006b. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071.
52. Liu J, Cao L, Chen J, Song S, Lee IH, Quijano C, Liu H, Keyvanfar K, Chen H, Cao LY, Ahn BH, Kumar NG, Rovira II, Xu XL, van Lohuizen M, Motoyama N, Deng CX, Finkel T,. 2009. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459: 387-392.
53. Maertens GN, El Messaoudi-Aubert S, Racek T, Stock JK, Nicholls J, Rodriguez-Niedenfuhr M, Gil J, Peters G,. 2009. Several distinct polycomb complexes regulate and co-localize on the Ink4a tumor suppressor locus. PLoS ONE 4: e6380.
54. Malik R, Lenobel R, Santamaria A, Ries A, Nigg EA, Korner R,. 2009. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res 8: 4553-4563.
55. Meng S, Luo M, Sun H, Yu X, Shen M, Zhang Q, Zhou R, Ju X, Tao W, Liu D, Deng H, Lu Z,. 2010. Identification and characterization of Bmi-1-responding element within the human p16 promoter. J Biol Chem 285: 33219-33229.
56. Merkerova M, Bruchova H, Kracmarova A, Klamova H, Brdicka R,. 2007. Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation. Leuk Lymphoma 48: 793-801. (Pubitemid 46605553)
57. Nakase I, Lai H, Singh NP, Sasaki T,. 2008. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 354: 28-33. (Pubitemid 351400327)
58. Nowak K, Kerl K, Fehr D, Kramps C, Gessner C, Killmer K, Samans B, Berwanger B, Christiansen H, Lutz W,. 2006. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res 34: 1745-1754.
59. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF,. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423: 302-305. (Pubitemid 40852701)
60. Peltz SW, Welch EM, Trotta CR, Davis T, Jacobson A,. 2009. Targeting post-transcriptional control for drug discovery. RNA Biol 6: 329-334.
61. Prince HM, Honemann D, Spencer A, Rizzieri DA, Stadtmauer EA, Roberts AW, Bahlis N, Tricot G, Bell B, Demarini DJ, Benjamin SA, Baker KL, Pandite LN,. 2009. Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: A phase 2 study of pazopanib (GW786034). Blood 113: 4819-4820.
62. Rizo A, Olthof S, Han L, Vellenga E, de Haan G, Schuringa JJ,. 2009. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood 114: 1498-1505.
63. Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan HG, Schuringa JJ,. 2010. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 116: 4621-4630.
64. Schuringa JJ, Vellenga E,. 2010. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Curr Opin Hematol 17: 294-299.
65. Silva J, Garcia JM, Pena C, Garcia V, Dominguez G, Suarez D, Camacho FI, Espinosa R, Provencio M, Espana P, Bonilla F,. 2006. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16Ink4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas. Clin Cancer Res 12: 6929-6936. (Pubitemid 44974485)
66. Simon JA, Kingston RE,. 2009. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
67. Singh A, Settleman J,. 2010. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
68. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL, Li MZ, Zhang L, Kang TB, Fu LW, Huang WL, Xia YF, Tsao SW, Li M, Band V, Band H, Shi QH, Zeng YX, Zeng MS,. 2009. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636.
69. Song W, Tao K, Li H, Jin C, Song Z, Li J, Shi H, Li X, Dang Z, Dou K,. 2010. Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci 101: 1754-1760.
70. Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT, Prince ME,. 2011. Head and neck cancer stem cells: The side population. Laryngoscope 121: 527-533.
71. Trimarchi JM, Fairchild B, Wen J, Lees JA,. 2001. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci USA 98: 1519-1524. (Pubitemid 32165531)
72. van der Lugt NM, Alkema M, Berns A, Deschamps J,. 1996. The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. Mech Dev 58: 153-164. (Pubitemid 26302233)
73. van Galen JC, Muris JJ, Oudejans JJ, Vos W, Giroth CP, Ossenkoppele GJ, Otte AP, Raaphorst FM, Meijer CJ,. 2007. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL. J Clin Pathol 60: 167-172.
74. van Gosilga D, Schepers H, Rizo A, van der Kolk D, Vellenga E, Schuringa JJ,. 2007. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. Exp Hematol 35: 1538-1549. (Pubitemid 47419138)
75. Venkataraman S, Alimova I, Fan R, Harris P, Foreman N, Vibhakar R,. 2010. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS ONE 5: e10748.
76. Voncken JW, Schweizer D, Aagaard L, Sattler L, Jantsch MF, van Lohuizen LM,. 1999. Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci 112 (Pt 24): 4627-4639. (Pubitemid 30034811)
77. Voncken JW, Niessen H, Neufeld B, Rennefahrt U, Dahlmans V, Kubben N, Holzer B, Ludwig S, Rapp UR,. 2005. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem 280: 5178-5187. (Pubitemid 40279988)
78. Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, Knizetova P, Hajduch M, Klein J, Kolek V, Radova L, Kolar Z,. 2008. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol 134: 1037-1042.
79. Wang H, Pan K, Zhang HK, Weng DS, Zhou J, Li JJ, Huang W, Song HF, Chen MS, Xia JC,. 2008. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 535-541. (Pubitemid 351422607)
80. Wu J, Hu D, Yang G, Zhou J, Yang C, Gao Y, Zhu Z,. 2011a. Down-regulation of BMI-1 cooperates with Artemisinin on growth inhibition of nasopharyngeal carcinoma cells. J Cell Biochem 112: 1938-1948.
81. Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G, Wang Y,. 2011b. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS ONE 6: e14648.
82. Yadav AK, Sahasrabuddhe AA, Dimri M, Bommi PV, Sainger R, Dimri GP,. 2010. Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain. Mol Cancer 9: 158.
83. Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC, Ma Y,. 2007. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA 104: 10494-10499. (Pubitemid 47185693)
84. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ,. 2010. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: 982-992.
85. Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS, Tseng LM, Hung SC, Kao SY, Chang CJ, Chiou SH,. 2011. Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol.